Clinical trials
Phase 1 Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
829 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 7 |
| 2002 | 8 |
| 2003 | 14 |
| 2004 | 12 |
| 2005 | 20 |
| 2006 | 17 |
| 2007 | 23 |
| 2008 | 37 |
| 2009 | 22 |
| 2010 | 21 |
| 2011 | 23 |
| 2012 | 33 |
| 2013 | 22 |
| 2014 | 42 |
| 2015 | 34 |
| 2016 | 25 |
| 2017 | 40 |
| 2018 | 37 |
| 2019 | 45 |
| 2020 | 39 |
| 2021 | 54 |
| 2022 | 48 |
| 2023 | 37 |
| 2024 | 49 |
| 2025 | 35 |
| 2026 | 51 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 382 |
| Terminated | 134 |
| Recruiting | 106 |
| Unknown status | 79 |
| Active, not recruiting | 55 |
| Not yet recruiting | 39 |
| Withdrawn | 29 |
| Suspended | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 31 |
| Celgene | 25 |
| Memorial Sloan Kettering Cancer Center | 18 |
| Washington University School of Medicine | 17 |
| AbbVie | 14 |
| Mayo Clinic | 14 |
| Novartis Pharmaceuticals | 14 |
| Institute of Hematology & Blood Diseases Hospital, China | 13 |
| Janssen Research & Development, LLC | 13 |
| Amgen | 12 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 829 |
| Lymphoma, Non-Hodgkin | 125 |
| Recurrence | 112 |
| Neoplasms, Plasma Cell | 106 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 99 |
| Lymphoma | 96 |
| Leukemia, Myeloid, Acute | 95 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 93 |
| Hodgkin Disease | 89 |
| Lymphoma, Large B-Cell, Diffuse | 85 |
Trials
Showing 76 to 100 of 829. Each trial links to its page on Pharma Observatory.
729 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.